Drug Shortage Report for RECOMBIVAX HB
| Report ID | 52350 |
| Drug Identification Number | 02245977 |
| Brand name | RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE) |
| Common or Proper name | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 40MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1DOSE VIAL |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-06-18 |
| Actual start date | 2018-06-18 |
| Estimated end date | 2021-04-05 |
| Actual end date | 2021-03-15 |
| Shortage status | Resolved |
| Updated date | 2021-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2021-03-16 | English | Compare |
| v20 | 2021-03-15 | English | Compare |
| v19 | 2021-02-03 | English | Compare |
| v18 | 2019-09-09 | French | Compare |
| v17 | 2019-09-09 | English | Compare |
| v16 | 2019-07-04 | French | Compare |
| v15 | 2019-07-04 | English | Compare |
| v14 | 2019-07-04 | English | Compare |
| v13 | 2018-12-11 | English | Compare |
| v12 | 2018-10-15 | English | Compare |
| v11 | 2018-10-15 | English | Compare |
| v10 | 2018-10-15 | English | Compare |
| v9 | 2018-08-30 | English | Compare |
| v8 | 2018-06-19 | English | Compare |
| v7 | 2018-06-18 | French | Compare |
| v6 | 2018-06-18 | English | Compare |
| v5 | 2018-06-14 | English | Compare |
| v4 | 2018-06-14 | English | Compare |
| v3 | 2018-06-13 | French | Compare |
| v2 | 2018-06-13 | English | Compare |